Genetic changes have been shown to be important in determining the multistep progression of cancer. Allele loss studies and karyotypic analysis of epithelial ovarian tumours have indicated the presence of putative w m u r suppressor genes on chromosomes 6, I I, I 3, 17, I8,22, and X. We have focused
Allelic loss in ovarian cancer
β Scribed by Teresa L. Yang-Feng; Hong Han; Kuang-Chao Chen; Shi-Bo Li; Elizabeth B. Claus; Maria L. Carcangiu; Setsuko K. Chambers; Joseph T. Chambers; Peter E. Schwartz
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- French
- Weight
- 618 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Loss of heterozygosity (LOH) was examined at 86 loci distributed on every chromosomal arm in 50 human ovarian tumors. Frequent allele losses were observed on chromosomes 13q (42%), I7p (42%), 17q YO), and X p (4 I Yo). Deletion mapping on chromosome I 7 revealed a candidate gene on the long arm distal to D17S41 /S74 for ovarian cancer which is distant from the locus for early onset breast cancer. LOH on chromosome 17q was found to be concordant with LOH on chromosomes 3p, 13q, 17p and Xp suggesting that it may be an early event in neoplastic development. These findings indicate that multiple tumor-suppressor genes for ovarian cancer possibly exist on chromosomes 13q. 17, and/or Xp and provide the basis for the identification of candidate gene@) associated with ovarian cancer. The chromosomal mechanisms resulting in allele losses in ovarian cancer include deletion, deletion/duplication, mitotic recombination and monosomy, in concordance with the developed genetic model.
π SIMILAR VOLUMES
Chromosomal deletions, associated with the loss of normal function of tumour suppressor genes, have been identified in a variety of both familial and sporadic human cancers. Although the molecular pathology of ovarian cancer is not understood, several studies have reported deletions in chromosome I7
Molecular genetic analyses of human prostate cancer (CaP) has revealed frequent loss of specific chromosome regions suggesting the presence of putative tumor suppressor gene(s) (TSG) on these chromosome loci whose inactivation may play a role in prostate tumorigenesis. To understand the role of 6q a
The PTEN/MMAC1/TEP1 tumor-suppressor gene, which maps to chromosome 10q23.3, is mutated and homozygously deleted in a variety of human tumors, including endometrioidtype ovarian tumors. We examined 33 primary ovarian cancers and 3 ovarian borderline tumors for allelic imbalance (AI) of the 10q23.3 r
The relatively frequent loss of heterozygosity at loci on the short arm of chromosome I I in human lung cancers has suggested the presence of a putative tumor suppressor gene. For location of the gene, a fine deletion map of human chromosome I I was constructed by analysis of DNAs from 79 lung cance
## Abstract Recent genomeβwide scans identified several novel breast cancer risk alleles, including variants of the __FGFR2__, __MAP3K1__ and __LSP1__ genes, and a study of associations between these alleles and characteristics of breast cancer patients reported a borderline significant correlation